Sponsor:
Masonic Cancer Center, University of Minnesota
Code:
NCT05735717
Conditions
Hematologic Malignancy
Acute Leukemia
Remission
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Eligibility Criteria
Sex: All
Age: 0 - 60
Healthy Volunteers: Not accepted
Interventions
Fludarabine
Busulfan
Melphalan
Rituximab
Levetiracetam
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Masonic Cancer Center, University of Minnesota on 2025-07-24.